Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196365 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
A Phase 3 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 97
- Enrollment target
NCT00196365 is a Phase 3 study that has completed, run by Duramed Research. The registered enrollment target is 97 participants.
The verdict
NCT00196365, a Phase 3 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 97 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 26 weeks of treatment. The overall study duration will be approximately 9 months. Patients will be required to record menstrual pain in a daily diary.
Interventions
- DRUG levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets
- DRUG levonorgestrel/EE 0.15/0.03 mg tablets and placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00196365
The ClinicalTrials.gov registry entry for NCT00196365 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets is the first listed.
NCT00196365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00196365 about?
NCT00196365 is a clinical study titled "A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain". This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 26 weeks of treatment. The overall study duration will be approximately 9...
What is the current status of trial NCT00196365?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 97 participants. The study started on 2005-01. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00196365?
The interventions under investigation include: levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets (DRUG), levonorgestrel/EE 0.15/0.03 mg tablets and placebo (DRUG).
Who is sponsoring clinical trial NCT00196365?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.